These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24330028)

  • 1. Preventive oral surgery before bisphosphonate administration to reduce osteonecrosis of the jaws.
    Mozzati M; Maggiora M; Scoletta M; Vasta A; Canuto R; Muzio G
    Oral Dis; 2014 Nov; 20(8):809-14. PubMed ID: 24330028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid.
    Mozzati M; Martinasso G; Maggiora M; Scoletta M; Zambelli M; Carossa S; Oraldi M; Muzio G; Canuto RA
    Clin Oral Investig; 2013 May; 17(4):1259-66. PubMed ID: 22864527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
    Lee CY; Suzuki JB
    Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: technical report and follow up of 21 patients.
    Voss PJ; Joshi Oshero J; Kovalova-Müller A; Veigel Merino EA; Sauerbier S; Al-Jamali J; Lemound J; Metzger MC; Schmelzeisen R
    J Craniomaxillofac Surg; 2012 Dec; 40(8):719-25. PubMed ID: 22336489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw.
    Heufelder MJ; Hendricks J; Remmerbach T; Frerich B; Hemprich A; Wilde F
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):e429-35. PubMed ID: 23182374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws.
    Wutzl A; Pohl S; Sulzbacher I; Seemann R; Lauer G; Ewers R; Drach J; Klug C
    Head Neck; 2012 Feb; 34(2):194-200. PubMed ID: 21400630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment.
    Otto S; Schreyer C; Hafner S; Mast G; Ehrenfeld M; Stürzenbaum S; Pautke C
    J Craniomaxillofac Surg; 2012 Jun; 40(4):303-9. PubMed ID: 21676622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis of the jaws associated with the use of bisphosphonates. Discussion over 52 cases.
    Almăşan HA; Băciuţ M; Rotaru H; Bran S; Almăşan OC; Băciuţ G
    Rom J Morphol Embryol; 2011; 52(4):1233-41. PubMed ID: 22203928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national-scale cohort study on bisphosphonate-related osteonecrosis of the jaw in Taiwan.
    Yuh DY; Chang TH; Huang RY; Chien WC; Lin FG; Fu E
    J Dent; 2014 Oct; 42(10):1343-52. PubMed ID: 24907558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.
    DE Iuliis F; Taglieri L; Amoroso L; Vendittozzi S; Blasi L; Salerno G; Lanza R; Scarpa S
    Anticancer Res; 2014 May; 34(5):2477-80. PubMed ID: 24778063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiresorptives and osteonecrosis of the jaw.
    Yamashita J; McCauley LK
    J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.
    Fleisher KE; Jolly A; Venkata UD; Norman RG; Saxena D; Glickman RS
    J Oral Maxillofac Surg; 2013 Mar; 71(3):513-9. PubMed ID: 22999296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy.
    Janovská Z
    Acta Medica (Hradec Kralove); 2012; 55(3):111-5. PubMed ID: 23297518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases.
    Tam Y; Kar K; Nowzari H; Cha HS; Ahn KM
    Clin Implant Dent Relat Res; 2014 Oct; 16(5):751-61. PubMed ID: 23445465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.
    Pavkovic M; Petrushevska G; Jovanovic R; Karanfilski O; Cevreska L; Stankovic S; Stojanovic A
    Prilozi; 2010; 31(2):39-49. PubMed ID: 21258276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment.
    Kwon TG; Lee CO; Park JW; Choi SY; Rijal G; Shin HI
    Clin Oral Implants Res; 2014 May; 25(5):632-40. PubMed ID: 23278625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis.
    Tennis P; Rothman KJ; Bohn RL; Tan H; Zavras A; Laskarides C; Calingaert B; Anthony MS
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):810-7. PubMed ID: 22711458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.